Skip to main content
915 TLDR
Health
1 read

El Paso's Dr. Nickel Leads Groundbreaking Lung Care Study

KVIARishi Oza
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

Dr. Nils Nickel, a pulmonologist at Texas Tech University Health Sciences Center, has been appointed as the principal investigator for a significant national study in El Paso aimed at advancing lung care. This research focuses on a new medication, TS23, designed to treat pulmonary embolism by dissolving blood clots more effectively and safely than current methods. With El Paso emerging as a leading site for participant enrollment, the study aims to enhance access to innovative treatments in an area that often faces healthcare limitations. Dr. Nickel emphasizes the importance of including El Paso in cutting-edge medical research to improve local healthcare options.

Key Details: • Dr. Nickel is leading a national study on a new lung treatment called TS23. • The study focuses on pulmonary embolism, a condition caused by blood clots in the lungs. • TS23 can be administered via IV, requiring less specialized personnel and equipment. • El Paso is one of the highest enrollment sites for this study in the U.S. • The study aims to enhance local access to clinical trials and innovative treatments.

healthcare texas-tech research clinical-trials pulmonary

People & Organizations

El PasoTexas Tech University Health Sciences CenterNils Nickel

Related Articles